Series B - CymaBay Therapeutics
Investment Firm
Overview
CymaBay Therapeutics is focused on the development and commercialization of proprietary new medicines for critical human diseases.
Announced Date
Dec 01, 2004
Funding Type
Series B
Highlights
Location
United States, North America
Social
Participant Investors
7
Round Details and Background
CymaBay Therapeutics raised $44000000 on 2004-12-01 in Series B
CymaBay Therapeutics is focused on the development and commercialization of proprietary new medicines for critical human diseases.
Company Funding History
16
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 11, 2013 |  Debt Financing - CymaBay Therapeutics | 2 | - | 5.0M |
| Oct 11, 2013 | Venture Round - CymaBay Therapeutics | - | 26.8M | |
| Apr 19, 2007 | Series D - CymaBay Therapeutics | 15 | - | 32.0M |
| Nov 05, 2009 | Series E - CymaBay Therapeutics | 12 | - | 8.6M |
Recent Activity
There is no recent news or activity for this profile.